Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload

Journal of Magnetic Resonance Imaging

Volumn 41, Issue 6, 2015, Pages 1505-1511

  Sado, Daniel M ^a,b   Maestrini, Viviana ^c   Piechnik, Stefan K ^d   Banypersad, Sanjay M ^a,b   White, Steven K ^a,b   Flett, Andrew S ^a   Robson, Matthew D ^d   Neubauer, Stefan ^d   Ariti, Cono ^e   Arai, Andrew ^f   Kellman, Peter ^f   Yamamura, Jin ^g   Schoennagel, Bjoern P ^g   Shah, Farrukh ^h   Davis, Bernard ^h   Trompeter, Sara ⁱ   Walker, Malcolm ^a,b   Porter, John ⁱ   Moon, James C ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h WHITTINGTON HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

iron; MRI; T1

Indexed keywords

IRON;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL T1 MAPPING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGICAL PROCEDURES; REPEAT PROCEDURE; REPRODUCIBILITY; COMPUTER ASSISTED DIAGNOSIS; HEART MUSCLE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84930017840     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24727     Document Type: Article

References (40)

1. Hershko C, Link G, Cabantchik I,. Pathophysiology of iron overload. Ann N Y Acad Sci 1998; 850: 191-201.
2. Gujja P, Rosing DR, Tripodi DJ, Shizukuda Y,. Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol 2010; 56: 1001-1012.
3. Modell B, Khan M, Darlison M,. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2000; 355: 2051-2052.
4. Sheth S,. Iron chelation: an update. Curr Opin Hematol 2014; 21: 179-185.
5. Wacker P, Halperin DS, Balmer-Ruedin D, Oberhansli I, Wyss M,. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. Chest 1993; 103: 1276-1278.
6. Anderson LJ, Holden S, Davis B, et al., Cardiovascular T2-star (T2∗) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171-2179.
7. Carpenter JP, He T, Kirk P, et al., On T2∗ magnetic resonance and cardiac iron. Circulation 2011; 123: 1519-1528.
8. Kirk P, He T, Anderson LJ, et al., International reproducibility of single breathhold T2∗ MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging 2010; 32: 315-319.
9. Kirk P, Smith GC, Roughton M, He T, Pennell DJ,. Myocardial T2∗ is not affected by ageing, myocardial fibrosis, or impaired left ventricular function. J Magn Reson Imaging 2010; 32: 1095-1098.
10. Wood JC,. History and current impact of cardiac magnetic resonance imaging on the management of iron overload. Circulation 2009; 120: 1937-1939.
11. Wood JC, Otto-Duessel M, Aguilar M, et al., Cardiac iron determines cardiac T2∗, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005; 112: 535-543.
12. Wood JC, Fassler JD, Meade T,. Mimicking liver iron overload using liposomal ferritin preparations. Magn Reson Med 2004; 51: 607-611.
13. Feng Y, He T, Carpenter JP, et al., In vivo comparison of myocardial T1 with T2 and T2∗ in thalassaemia major. J Magn Reson Imaging 2013; 38: 588-593.
14. White SK, Sado DM, Flett AS, Moon JC,. Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging. Heart 2012; 98: 773-779.
15. Piechnik SK, Ferreira VM, Dall'Armellina E, et al., Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010; 12: 69.
16. Kellman P, Wilson JR, Xue H, Ugander M, Arai AE,. Extracellular volume fraction mapping in the myocardium. Part 1: Evaluation of an automated method. J Cardiovasc Magn Reson 2012; 14: 63.
17. Bossuyt PM, Reitsma JB, Bruns DE, et al., Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003; 326: 41-44.
18. Tanner MA, Galanello R, Dessi C, et al., A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 2007; 115: 1876-1884.
19. Piechnik SK, Ferreira VM, Lewandowski AJ, et al., Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5T using ShMOLLI. J Cardiovasc Magn Reson 2013; 15: 13.
20. Westwood M, Anderson LJ, Firmin DN, et al., A single breath-hold multiecho T2∗ cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003; 18: 33-39.
21. Pennell DJ, Udelson JE, Arai AE, et al., Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association. Circulation 2013; 128: 281-308.
22. Yamamura J, Grosse R, Graessner J, Janka GE, Adam G, Fischer R,. Distribution of cardiac iron measured by magnetic resonance imaging (MRI)-R∗2. J Magn Reson Imaging 2010; 32: 1104-1109.
23. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ,. Improved survival of thalassaemia major in the UK and relation to T2∗ cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008; 10: 42.
24. Westwood MA, Firmin DN, Gildo M, et al., Intercentre reproducibility of magnetic resonance T2∗ measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging 2005; 21: 531-538.
25. Liu P, Henkelman M, Joshi J, et al., Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model. Can J Cardiol 1996; 12: 155-164.
26. Stark DD, Bass NM, Moss AA, et al., Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology 1983; 148: 743-751.
27. Engelhardt R, Langkowski JH, Fischer R, et al., Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis. Magn Reson Imaging 1994; 12: 999-1007.
28. Gai ND, Stehning C, Nacif M, Bluemke DA,. Modified Look-Locker T1 evaluation using Bloch simulations: human and phantom validation. Magn Reson Med 2013; 69: 329-336.
29. Ferreira VM, Piechnik SK, Dall'Armellina E, et al., Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012; 14: 42.
30. Karamitsos TD, Piechnik SK, Banypersad SM, et al., Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 2013; 6: 488-497.
31. Dass S, Suttie JJ, Piechnik SK, et al., Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 2012; 5: 726-733.
32. Kirk P, Carpenter JP, Tanner MA, Pennell DJ,. Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2011; 13: 8.
33. Sado DM, White SK, Piechnik SK, et al., Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 2013; 6: 392-398.
34. Pedersen SF, Thrysoe SA, Robich MP, et al., Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction. J Cardiovasc Magn Reson 2012; 14: 59.
35. Goldfarb JW, Arnold S, Roth M, Han J,. T1-weighted magnetic resonance imaging shows fatty deposition after myocardial infarction. Magn Reson Med 2007; 57: 828-834.
36. Collins W, Taylor WH,. Determination of iron in cardiac and liver tissues by plasma emission spectroscopy. Ann Clin Biochem 1987; 24 (Pt 5): 483-487.
37. Wood JC, Enriquez C, Ghugre N, et al., MRI R2 and R2∗ mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106: 1460-1465.
38. Ramazzotti A, Pepe A, Positano V, et al., Multicenter validation of the magnetic resonance T2∗ technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging 2009; 30: 62-68.
39. Chow K, Flewitt J, Pagano J, Green J, Friedrich M, Thompson R,. T2-dependent errors in MOLLI T1 values: simulations, phantoms and in-vivo studies. J Cardiovasc Magn Reson 2012; 14: P281.
40. Raman SV, Phatak K, Hoyle JC, et al., Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome. Eur Heart J 2011; 32: 561-567.